{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:09:20Z","timestamp":1778940560496,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11288"],"award-info":[{"award-number":["25K11288"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KD2505"],"award-info":[{"award-number":["KD2505"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omton.2025.201004","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:53:33Z","timestamp":1749056013000},"page":"201004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel immunotherapy for multiple myeloma involving activation of plasmacytoid dendritic cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Masayuki","family":"Kurimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-8064","authenticated-orcid":false,"given":"Tomohiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201004_bib1","article-title":"Enhancing Plasmacytoid Dendritic Cell Functionality with All-Trans Retinoic Acid for Improved Multiple Myeloma Therapy","volume":"33","author":"Yu","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.omton.2025.201004_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2025.201004_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167910","article-title":"A positive cytokine\/chemokine feedback loop establishes plasmacytoid DC-driven autoimmune pancreatitis in IgG4-related disease","volume":"9","author":"Hara","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.omton.2025.201004_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2009.08.019","article-title":"Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target","volume":"16","author":"Chauhan","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201004_bib5","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI121421","article-title":"E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs","volume":"128","author":"Bi","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.201004_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.it.2016.12.006","article-title":"Retinoic Acid and Immune Homeostasis: A Balancing Act","volume":"38","author":"Erkelens","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omton.2025.201004_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2025.201004_bib8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood-2012-04-403733","article-title":"Proteasome inhibitors in multiple myeloma: 10 years later","volume":"120","author":"Moreau","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201004_bib9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2020.02.042","article-title":"Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression","volume":"180","author":"Devalaraja","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.201004_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/intimm\/dxab103","article-title":"Transcription factor MafB-mediated inhibition of type I interferons in plasmacytoid dendritic cells","volume":"34","author":"Saiga","year":"2022","journal-title":"Int. Immunol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:37:39Z","timestamp":1778938659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2950329925000736"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201004","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel immunotherapy for multiple myeloma involving activation of plasmacytoid dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201004"}}